Earnings History Data for Denali Therapeutics (DNLI) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Denali Therapeutics

Denali Therapeutics Inc. is a biotechnology company. It focused on the discovery and development of therapies for patients with neurodegenerative disease, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis and others. Denali Therapeutics Inc. is based in SOUTH SAN FRANCISCO, United States.

Release Date	Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
27-02-2025	AH	DNLI	Denali Therapeutics	2,763	-0.67	-0.83	0.00	Denali Therapeutics GAAP EPS of -$0.67 beats by $0.13 [2/27/2025 4:47 PM]	16.52	-2.09 (-11.21%)	18.80	0.20 (1.08%)	14.56 - 33.33	1,589,139	760,000	18,605
Denali Therapeutics GAAP EPS of -$0.67 beats by $0.13 [2/27/2025 4:47 PM] Denali Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights [2025-02-27 04:01PM]
01-08-2024	PM	DNLI	Denali Therapeutics	3,453	-0.59	-0.68	0.00	Denali Therapeutics GAAP EPS of -$0.59 beats by $0.11 [8/1/2024 8:47 AM]	23.34	-1.03 (-4.21%)	23.20	-1.17 (-4.80%)	14.56 - 28.35	1,091,514	1,020,000	835
Denali Therapeutics GAAP EPS of -$0.59 beats by $0.11 [8/1/2024 8:47 AM]
07-05-2024	AH	DNLI	Denali Therapeutics	2,443	-0.68	-0.67	0.00	Denali Therapeutics GAAP EPS of -$0.68 beats by $0.02 [5/7/2024 5:47 PM]	18.80	1.95 (11.60%)	16.85	0.0 (0.00%)	14.56 - 33.31	2,246,509	1,000,000	295,069
Denali Therapeutics GAAP EPS of -$0.68 beats by $0.02 [5/7/2024 5:47 PM]
27-02-2024	PM	DNLI	Denali Therapeutics Inc.	2,330	-0.86	-0.82	-0.75	Denali Therapeutics GAAP EPS of -$0.86 [2/27/2024 9:12 AM]	23.39	6.50 (38.48%)	19.75	2.86 (16.93%)	15.45 - 33.31	4,344,767	1,440,000	42,594
Denali Therapeutics GAAP EPS of -$0.86 [2/27/2024 9:12 AM] Denali spikes after $500M private placement [2/27/2024 10:06 AM]
07-11-2023	AH	DNLI	Denali Therapeutics	2,999	-0.72	-0.83	0.00	Denali Therapeutics GAAP EPS of -$0.72 beats by $0.09, revenue of $1.27M misses by $9.89M [11/7/2023 5:20 PM]	20.18	-1.05 (-4.97%)	21.64	0.41 (1.93%)	17.98 - 33.31	972,865	890,000	15,480
Denali Therapeutics GAAP EPS of -$0.72 beats by $0.09, revenue of $1.27M misses by $9.89M [11/7/2023 5:20 PM]
08-08-2023	AH	DNLI	Denali Therapeutics	3,784	1.30	-0.86	0.00	Denali Therapeutics EPS of $1.30, revenue of $294.12M beats by $254.61M [8/8/2023 5:16 PM]	24.77	-1.06 (-4.10%)	26.67	0.84 (3.25%)	21.74 - 39.43	1,076,042	480,000	1,229
Denali Therapeutics EPS of $1.30, revenue of $294.12M beats by $254.61M [8/8/2023 5:16 PM]
08-05-2023	AH	DNLI	Denali Therapeutics	3,619	-0.80	-0.71	0.00	Denali Therapeutics GAAP EPS of -$0.80 misses by $0.10, revenue of $35.14M beats by $5.26M [5/8/2023 5:13 PM]	27.38	0.82 (3.07%)	26.56	0.0 (0.00%)	20.24 - 39.43	450,852	660,000	9,785
Denali Therapeutics GAAP EPS of -$0.80 misses by $0.10, revenue of $35.14M beats by $5.26M [5/8/2023 5:13 PM]
08-08-2022	AH	DNLI	Denali Therapeutics	4,106	-0.48	-0.52	0.00	Denali Therapeutics GAAP EPS of -$0.48 beats by $0.04, revenue of $52.48M beats by $7.82M [8/8/2022 5:45 PM]	37.27	0.02 (0.05%)	37.25	0.0 (0.00%)	20.24 - 56.80	694,411	620,000	24,882
Denali Therapeutics GAAP EPS of -$0.48 beats by $0.04, revenue of $52.48M beats by $7.82M [8/8/2022 5:45 PM] Denali Therapeutics Reports Second Quarter 2022 Financial Results and Business Highlights [Aug-08-22 04:01PM]
05-05-2022	AH	DNLI	Denali Therapeutics	3,139	-0.53	-0.47	0.00	Denali Therapeutics GAAP EPS of -$0.53 misses by $0.03, revenue of $42.14M beats by $8.82M [5/5/2022 5:45 PM]	23.01	-0.96 (-4.00%)	23.97	0.0 (0.00%)	22.52 - 79.70	588,395	470,000	169
Denali Therapeutics GAAP EPS of -$0.53 misses by $0.03, revenue of $42.14M beats by $8.82M [5/5/2022 5:45 PM] Denali Therapeutics Reports First Quarter 2022 Financial Results and Business Highlights [May-05-22 04:01PM] AVEO Pharmaceuticals (AVEO) Reports Q1 Loss, Misses Revenue Estimates [May-05-22 08:35AM] Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Tops Revenue Estimates [May-05-22 05:55PM]
28-02-2022	AH	DNLI	Denali Therapeutics	4,020	-0.62	-0.41	0.00	Denali Therapeutics GAAP EPS of -$0.62 misses by $0.16, revenue of $12.51M misses by $32.31M [2/28/2022 5:15 PM]	32.10	-0.46 (-1.41%)	32.56	0.0 (0.00%)	30.25 - 79.70	515,302	480,000	77,545
Denali Therapeutics GAAP EPS of -$0.62 misses by $0.16, revenue of $12.51M misses by $32.31M [2/28/2022 5:15 PM] Denali Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights [Feb-28-22 04:01PM] Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs [Feb-28-22 09:00AM] Denali Therapeutics Inc. (DNLI) Reports Q4 Loss, Misses Revenue Estimates [Feb-28-22 05:25PM] Denali (DNLI) Q4 Loss Wider Than Expected, Revenues Lag [Mar-01-22 11:36AM]
04-08-2021	AH	DNLI	Denali Therapeutics Inc.	6,118	-0.50	-0.37	0.00	Denali Therapeutics EPS misses by $0.11, misses on revenue [8/4/2021 5:03 PM]	52.96	2.08 (4.09%)	50.88	0.0 (0.00%)	22.75 - 93.94	389,532	770,000	11,629
Denali Therapeutics EPS misses by $0.11, misses on revenue [8/4/2021 5:03 PM] Denali Therapeutics Reports Second Quarter 2021 Financial Results and Business Highlights [Aug-04-21 04:01PM] Denali Therapeutics Inc. (DNLI) Reports Q2 Loss, Lags Revenue Estimates [Aug-04-21 05:45PM] Is Denali Therapeutics Inc.'s (NASDAQ:DNLI) Stock Price Struggling As A Result Of Its Mixed Financials? [Aug-05-21 03:26AM]
03-05-2021	PM	DNLI	Denali Therapeutics Inc.	7,431	-0.58	-0.37	0.00	Denali Therapeutics EPS misses by $0.21, misses on revenue [5/3/2021 8:53 AM]	58.33	-2.11 (-3.49%)	61.00	0.56 (0.93%)	21.41 - 93.94	422,413	440,000	2,487
Denali Therapeutics EPS misses by $0.21, misses on revenue [5/3/2021 8:53 AM] Denali presents positive results from early-stage studies of BIIB122/DNL151 in Parkinson’s disease [5/3/2021 2:50 AM] Denali Therapeutics Reports First Quarter 2021 Financial Results and Business Highlights [May-03-21 08:30AM] Is Denali Therapeutics Inc. (DNLI) A Smart Long-Term Buy? [Apr-30-21 01:32PM] Denali-Biogen Parkinson's Disease Candidate Shows Reductions In Biomarkers; Late Study To Begin By 2021 End [May-03-21 06:46AM] Denali Therapeutics Inc. (DNLI) Reports Q1 Loss, Misses Revenue Estimates [May-03-21 09:45AM]
25-02-2021	AH	DNLI	Denali Therapeutics Inc.	7,750	1.91	-0.55	-0.56	Denali Therapeutics EPS beats by $2.44, beats on revenue [2/25/2021 5:44 PM]	71.92	8.92 (14.16%)	64.85	1.85 (2.94%)	12.39 - 93.94	828,940	733,567	1,384
Denali Therapeutics EPS beats by $2.44, beats on revenue [2/25/2021 5:44 PM]